CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
出版年份 2021 全文链接
标题
CHFR regulates chemoresistance in triple-negative breast cancer through destabilizing ZEB1
作者
关键词
-
出版物
Cell Death & Disease
Volume 12, Issue 9, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-08-30
DOI
10.1038/s41419-021-04114-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Signaling pathways essential for triple-negative breast cancer stem-like cells
- (2021) Sidse Ehmsen et al. STEM CELLS
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- The great escape: tumour cell plasticity in resistance to targeted therapy
- (2019) Soufiane Boumahdi et al. NATURE REVIEWS DRUG DISCOVERY
- ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM
- (2018) Xiang Zhang et al. Cell Death & Disease
- ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer
- (2018) Peijing Zhang et al. Cell Reports
- Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
- (2018) Piyush B. Gupta et al. Cell Stem Cell
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
- (2017) Angela M. Krebs et al. NATURE CELL BIOLOGY
- Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer
- (2016) A. Giro-Perafita et al. CLINICAL CANCER RESEARCH
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance
- (2015) Peijing Zhang et al. CELL CYCLE
- Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
- (2014) Maria Angelica Cortez et al. MOLECULAR THERAPY
- ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1
- (2014) Peijing Zhang et al. NATURE CELL BIOLOGY
- ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1
- (2014) Yihua Wang et al. NATURE CELL BIOLOGY
- miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
- (2014) Peijing Zhang et al. Nature Communications
- Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
- (2013) Sarah Derks et al. CANCER AND METASTASIS REVIEWS
- Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
- (2013) Christine L. Chaffer et al. CELL
- Roadblocks to translational advances on metastasis research
- (2013) Thomas Brabletz et al. NATURE MEDICINE
- CHFR is important for the first wave of ubiquitination at DNA damage sites
- (2012) Chao Liu et al. NUCLEIC ACIDS RESEARCH
- SIRT1 induces EMT by cooperating with EMT transcription factors and enhances prostate cancer cell migration and metastasis
- (2012) V Byles et al. ONCOGENE
- MicroRNAs as regulators of epithelial-mesenchymal transition
- (2011) Philip A. Gregory et al. CELL CYCLE
- An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
- (2011) Philip A. Gregory et al. MOLECULAR BIOLOGY OF THE CELL
- Chfr and RNF8 synergistically regulate ATM activation
- (2011) Jiaxue Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
- (2009) Balazs Györffy et al. BREAST CANCER RESEARCH AND TREATMENT
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- Chfr is linked to tumour metastasis through the downregulation of HDAC1
- (2009) Young Mi Oh et al. NATURE CELL BIOLOGY
- CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-κB
- (2009) L Kashima et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started